Wedbush issued their FY2029 earnings estimates for Ovid Therapeutics in a note issued to investors on Wednesday, March 12th.
Air Products and Chemicals (NYSE:APD – Get Free Report) had its price objective cut by research analysts at UBS Group from ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback